Zinzino AB's Revenue Report for October 2025
Overview
Zinzino AB, a Swedish health and wellness company, has released its preliminary sales report for October 2025, showcasing an impressive 65% year-over-year revenue growth. The report highlights the company’s robust performance across its various sales markets, indicating continued consumer interest and market expansion.
Key Financial Highlights
In October alone, Zinzino's revenue reached SEK 324.8 million compared to SEK 191.6 million in the same month of the previous year, marking a 70% increase within its sales markets. However, Faun Pharma, Zinzino’s subsidiary, reported a decline in external sales, dropping to SEK 2.7 million from SEK 7.3 million in the previous year.
Overall, the group’s total revenue for October was SEK 327.5 million, rising significantly from SEK 198.9 million in 2024. For the period from January to October 2025, Zinzino's cumulative revenue was SEK 2,629.7 million, growing 55% from SEK 1,693.2 million recorded during the same timeframe last year.
Regional Performance
The strong performance can be attributed to substantial revenue boosts across several regions:
- - Nordics: Increased revenue from SEK 29.3 million to SEK 36.3 million, a 24% growth, totaling SEK 270.3 million year-to-date.
- - Central Europe: Remarkably high growth at 88%, with revenue jumping from SEK 53.9 million to SEK 101.3 million, totaling SEK 758.9 million year-to-date.
- - North America: The most striking growth recorded at 167%, with sales rising from SEK 19.3 million to SEK 51.6 million for October alone. Year-to-date revenue reached SEK 433.6 million.
- - Asia-Pacific: Witnessed a staggering 384% increase for October, with revenue climbing to SEK 28.1 million, from just SEK 5.8 million, demonstrating the region's potential for growth.
- - South West Europe: Reported a 56% increase, with revenue growing to SEK 57.8 million from SEK 37 million.
Interestingly, despite the phenomenal performance in other regions, the company observed relatively stable sales trends in East Europe and moderate increases from Africa. This diversified growth indicates Zinzino's ability to adapt to varying market conditions across different areas.
Conclusion
The preliminary sales report from Zinzino AB underscores the company's strategic initiatives and consumer popularity, affirming its position in the competitive health and wellness sector. This strong performance in October 2025 not only highlights Zinzino's successful business model but also establishes a solid foundation for future growth as consumer interest in health products continues to rise globally. As the company aims to innovate and expand further, investors and stakeholders will undoubtedly watch closely.
For more information, Dag Bergheim Pettersen, CEO of Zinzino, can be contacted at +47 (0) 932 25 700 or via email at
[email protected].